z-logo
open-access-imgOpen Access
Prevention of Corneal Neovascularization by Adenovirus Encoding Human Vascular Endothelial Growth Factor Soluble Receptor (s-VEGFR1) in Lacrimal Gland
Author(s) -
Luis Fernando Nominato,
Ana Carolina Dias,
Lara Cristina Dias,
Marina Zílio Fantucci,
Lilian Eslaine Costa Mendes da Silva,
Adriana de Andrade Batista Murashima,
Eduardo Melani Rocha
Publication year - 2018
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.17-22322
Subject(s) - lacrimal gland , corneal neovascularization , cornea , vascular endothelial growth factor , trigeminal ganglion , immunohistochemistry , medicine , microbiology and biotechnology , endocrinology , neovascularization , biology , pathology , ophthalmology , angiogenesis , vegf receptors , sensory system , neuroscience
The aims of this study were (1) to determine the efficacy of adenovirus vector serotype 5 (Ad) encoding human soluble VEGF receptor 1 (s-VEGFR1) gene transfer to the lacrimal gland (LG); (2) to investigate whether expression of s-VEGFR1 prevents corneal neovascularization (CNV) induced by alkali burns; and (3) to evaluate the safety of the procedure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom